Integrated Islet Distribution Program
Since 2002, City of Hope has led this vital program of coordinating multiple centers that isolate human islets from cadaveric donors and distribute those tissues equitably to investigators all over the world. Today, these efforts continue through the Integrated Islet Distribution Program (IIDP), funded by the National Institute of Diabetes and Digestive and Kidney Diseases, led by Joyce Niland, Ph.D. and supported by her team.
There currently are five islet isolation centers subcontracted through the IIDP:
- Scharp-Lacy Research Institute (Dr. David Scharp, Director)
- Southern California Islet Cell Resource Center, based at City of Hope (Dr. Fouad Kandeel, Director)
- University of Miami (Dr. Camillo Ricordi, Director)
- University of Pennsylvania (Dr. Ali Naji, Director)
- University of Wisconsin (Dr. Luis Fernandez, Director)
In addition to researchers having access to human islets in an effective and efficient manner as provided by the Integrated Islet Distribution Program (IIDP), it is imperative that these islets be accompanied with substantial donor data, pre- and post-shipment islet characterization, and statistical evaluation to increase their research value. The IIDP collects pre-shipment islet data from the 5 islet isolation centers. Beginning in 2017, the IIDP added the Human Islet Phenotyping Program through which post-shipment islets are characterized through multiple assays. This data will soon be released to the research community to aid in the study of human islets.
City of Hope’s Department of Diabetes & Cancer Discovery Science is home to the IIDP, and the grant’s principal investigator is Joyce Niland, Ph.D., holder of the Edward and Estelle Alexander Endowed Chair/Professor
The IIDP Role
The Integrated Islet Distribution Program provides infrastructure, informatics, statistical support, and management of processes essential to distributing human islets to researchers pursuing diabetes research studies using human islets.
- Coordinating islet distribution
The IIDP processes applications from investigators worldwide who seek human islets and maintains a database of the investigators approved to receive the islets. The IIDP also developed and manages a unique computerized optimization algorithm that determines how islets will be allocated, to ensure that distribution is equitable.
- Helping manage the islet supply
The IIDP is focused on meeting the evolving needs of the diabetes research community by tracking the supply and demand for human islets, and working with isolation centers to adjust production as needed. With the same focus on the research community’s needs, we act in close collaboration with the National Institutes of Health and an External Scientific Panel which advises the IIDP.
- Monitoring the quality of islets and standardizing shipment
The IIDP collects feedback from investigators and works closely with isolation centers to ensure that high-quality islets are provided to IIDP approved investigators. The Human Islet Phenotyping Program (HIPP) at Vanderbilt, subcontracted to IIDP, provides additional extensive quality and assay data for IIDP approved investigators.
- Supporting novel new research ideas
Funded by the Juvenile Diabetes Research Foundation (JDRF), the IIDP has established the Investigator Award Initiative (IAI), through which investigators, new to islet research or those with novel unfunded proposals, may apply to receive up to 100,000 islets free of charge to support their experiments and collect the pilot data needed for peer-review funding applications.
The IIDP Impact
Cumulative figures as of August 2018:
- 250 million islets distributed worldwide
- 350 research studies received islets since 2004
- 640 peer-reviewed publications stem from IIDP islets
Islets are available by application, requiring approval as well as a subscription fee to underwrite islet production.
For Early-Career Investigators and Those Seeking Bridge Funding
With generous funding from JDRF, the IIDP established the Islet Award Initiative (IAI). This grant covers the subscription fee for islets, enabling qualifying scientists to receive islets free of cost.